According to InvestorGain, the last grey market premium (GMP) for the Corona Remedies IPO stood at Rs 342.5 on Dec. 15. With ...

Unlike in the general population, women with stage 5 chronic kidney disease (CKD) do not have a sex-based survival advantage compared with men.

Corona Remedies Share Price, IPO Listing, GMP Live Updates: Corona Remedies is all set to hit the secondary market, after the ...

Researchers report that yoga and general exercise deliver similar sleep outcomes for women managing urinary incontinence.

Men and women often experience similar bladder symptoms, but the causes are completely different. With insights from Dr ...

Elevated Ca×P levels were associated with increased odds of developing hyperuricemia among adults in the US, especially those with overweight or obesity.

The FDA has approved GSK's gepotidacin (Blujepa), the first new antibiotic class for gonorrhea in over three decades, ...

The company aims to raise ₹655.37 crore from the book-building issue, which is entirely an offer for sale of 61.71 lakh ...

The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...

Corona Remedies’ shares made a strong debut on the stock market, gaining 36.72 per cent over its IPO price. The pharma ...

Lori Lerner, MD, associate professor of urology at Boston University Chobanian & Avedisian School of Medicine, is the recipient of the 2026 Distinguished Contribution Award from the American ...

Some experts believe the cancer label can be inappropriate for certain low-risk conditions and advocate dropping the C-word.